View original post here:

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh